About
Genocea Biosciences is a clinical-stage biotechnology company developing personalized cancer immunotherapies using its proprietary ATLAS platform to identify patient-specific immune targets.
Explore Genocea Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.